FDA takes action against the use of OTC benzocaine teething products due to serious safety risk, lack of benefit - FDA.gov

FDA takes action against the use of OTC benzocaine teething products due to serious safety risk, lack of benefit FDA.gov May 23, 2018. Release. The U.S. Food and Drug Administration is warning consumers that over-the-counter (OTC) teething products containing benzocaine pose a serious risk to infants and children. The agency today announced that OTC oral health ... and more »

from Health - Google News https://ift.tt/2s6aime